A clinical study of Embedded Wire Treatment on Back-Shu and Front-Mu Points to Obesity and type II diabetes mellitus Patients

A study on Food Intake Adjusting Mechanism of Embedded Wire Treatment on Back-Shu and Front-Mu Points to Obesity and type II diabetes mellitus Patients

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100047805

Enrollment

Unknown

Registered

2021-06-26

Start date

2020-06-22

Completion date

Unknown

Last updated

2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

overweight/obesity and type 2 diabetes

Interventions

control group:drug

experimental group:drug combined with catgut embeding

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Meets the diagnostic criteria of obesity and prediabetes at the same time; 2. Aged between 20 and 60 years old; 3. Have not used hypoglycemic drugs or insulin therapy in the past 3 months; 4. voluntarily participate in the clinical study, and sign the "informed consent".

Exclusion criteria

Exclusion criteria: 1. scar constitution, hypersensitivity constitution and absorbable suture allergy; 2. People with a history of allergy to the test drug or allergic constitution; 3. pregnant or preparing to be pregnant, lactating women; 4. Secondary obesity or secondary hyperglycemia; 5. serious heart, lung, liver, kidney, brain, tumor and other diseases; 6. patients with bleeding tendency.

Design outcomes

Primary

Measure	Time frame
body weight;BMI;Fasting Olasma Glucose;	—

Countries

China

Contacts

Public ContactRen Yuanyuan

Xi'an Hospital of Traditional Chinese Medicine

yuanyuan_ren@126.com+86 15389269056

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026